Aggressive Spinal Hemangioma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-30

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is a case series analysis to evaluate aggressive vertebral hemangiomas. It focuses on clinical presentation, diagnostic imaging accuracy (X-ray, MRI, MSCT, angiography), and treatment efficacy. The primary goal is to establish optimal management protocols.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Study on Leptomeningeal Metastasis of Solid Tumors

NCT06705049

Leptomeningeal Metastasis

ENROLLING_BY_INVITATION

Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Retrospective Analysis

NCT03991533

Head and Neck Cancer Multiparametric MRI Cervical Lymph Node

COMPLETED

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

NCT04458935

Retinal Hemangioblastoma Von Hippel-Lindau Disease

ACTIVE_NOT_RECRUITING

Craniopharyngioma With Tumoral Hemorrhage

NCT04937335

Craniopharyngioma Apoplexy

COMPLETED

Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors

NCT00907244

Brain Tumors

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hybrid methodology integrating retrospective case reviews (from Assiut University Hospital's Orthopedic Surgery Department) with synthesis of existing literature.

Objectives:

Characterize clinical presentations and imaging findings. Compare diagnostic accuracy across modalities. Analyze treatment outcomes, including procedural success rates and complications.

Tools:

Imaging: X-ray for initial screening, MRI/MSCT for soft tissue and spinal cord involvement, angiography for vascular mapping.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aggressive Spinal Hemangiomas

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with symptomatic, radiologically confirmed aggressive spinal hemangiomas treated at Assiut

Confirmed diagnosis of aggressive vertebral hemangioma via imaging (MRI/MSCT) and clinical symptoms (e.g., pain, neurological deficits).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with aggressive spinal hemangiomas based on clinical symptoms and imaging findings.
* Cases confirmed through diagnostic modalities such as X-ray, MRI, MSCT, or angiography.
* Patients presenting with symptoms such as pain, neurological deficits, or spinal instability attributable to the hemangioma.

Exclusion Criteria

* Patients with incidentally discovered spinal hemangiomas (asymptomatic cases found during evaluations for unrelated conditions).
* Cases lacking sufficient diagnostic evidence to confirm aggressive spinal hemangioma.

Eligible Sex

ALL

Accepts Healthy Volunteers

No